close

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.66
+0.39 (0.19%)
AAPL  273.89
+7.71 (2.90%)
AMD  210.64
+14.04 (7.14%)
BAC  49.61
-1.46 (-2.86%)
GOOG  307.96
-3.73 (-1.20%)
META  630.57
-6.68 (-1.05%)
MSFT  385.77
+1.30 (0.34%)
NVDA  190.71
-0.84 (-0.44%)
ORCL  143.36
+2.05 (1.45%)
TSLA  401.40
+1.57 (0.39%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today